A new study details the clinical characteristics of KCNA2-associated hereditary spastic paraplegia, highlighting the need for targeted treatment approaches. This research contributes to understanding the disease's genetic underpinnings and potential therapeutic strategies.
kcna2 associated hereditary spastic paraplegia clinical characteristics and rationale for targeted treatment
Original title: “KCNA2-Associated Hereditary Spastic Paraplegia: Clinical Characteristics and Rationale for Targeted Treatment.”